DCTH Delcath stock news
On August 28, 2026, Delcath Systems Inc. (Nasdaq: DCTH) announced that its management team is scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation, set for September 14, 2026, will feature a corporate overview and a progress report on the commercialization of the HEPZATO KIT in the United States. This engagement follows a period of significant growth for the company, including the recent activation of its 22nd treatment center, and is intended to provide institutional investors with updated insights into the company's strategic roadmap for the remainder of the fiscal year.